Back to ABN AMRO Bank N.V. ABN AMRO Bank N.V.

REGNREGN
Showing 8 of 13 quarters

Position history for ABN AMRO Bank N.V.ABN AMRO Bank N.V.'s holdings in REGENERON PHARMACEUTICALS

ABN AMRO Bank N.V. holds 678 shares of REGN (REGENERON PHARMACEUTICALS), worth $421,934 as of 2026-Q2. REGN represents 0.0% of ABN AMRO Bank N.V.'s portfolio.

Current Value

$421,934

Current Shares

678

Total Value Change

-$222.5M

Total Shares Change

-212,944

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
678
0.0%
$421,9340.0%$623.54
0
2026-Q1
Decreased
678
-0.6%
$526,2780.0%$766.66
0
2025-Q4
Decreased
682
-14.0%
$524,4720.0%$773.94
0
2025-Q3
Decreased
793
-13.2%
$444,3840.0%$560.05
0
2025-Q2
Decreased
914
-99.6%
$482,7620.0%$519.56
0
2025-Q1
Increased
221,483
+0.7%
$140.1M1.9%$634.66
48
2024-Q4
Increased
219,869
+2.9%
$155M2.1%$698.71
54
2024-Q3
Increased
213,622
+4.1%
$222.9M3.1%$1,036.94
59

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used